75000 - Document - Document and Entity Information
link:presentationLink
link:calculationLink
link:definitionLink
75010 - Statement - Condensed Consolidated Balance Sheets
link:presentationLink
link:calculationLink
link:definitionLink
75020 - Statement - Condensed Consolidated Balance Sheets (Parenthetical)
link:presentationLink
link:calculationLink
link:definitionLink
75030 - Statement - Condensed Consolidated Statements of Operations and Comprehensive (Loss) Income (Unaudited)
link:presentationLink
link:calculationLink
link:definitionLink
75040 - Statement - Condensed Consolidated Statements of Operations and Comprehensive (Loss) Income (Unaudited) 2
link:presentationLink
link:calculationLink
link:definitionLink
75050 - Statement - Condensed Consolidated Statements of Equity (Unaudited)
link:presentationLink
link:calculationLink
link:definitionLink
75060 - Statement - Condensed Consolidated Statements of Cash Flows (Unaudited)
link:presentationLink
link:calculationLink
link:definitionLink
995455 - Disclosure - Nature of Operations and Liquidity
link:presentationLink
link:calculationLink
link:definitionLink
995465 - Disclosure - Summary of Significant Accounting Policies
link:presentationLink
link:calculationLink
link:definitionLink
995475 - Disclosure - Fair Value Measurements and Financial Instruments
link:presentationLink
link:calculationLink
link:definitionLink
995485 - Disclosure - Balance Sheet Components
link:presentationLink
link:calculationLink
link:definitionLink
995495 - Disclosure - Intangible Assets
link:presentationLink
link:calculationLink
link:definitionLink
995505 - Disclosure - Revenue
link:presentationLink
link:calculationLink
link:definitionLink
995515 - Disclosure - Leases
link:presentationLink
link:calculationLink
link:definitionLink
995525 - Disclosure - Stockholders' Equity
link:presentationLink
link:calculationLink
link:definitionLink
995535 - Disclosure - Convertible Preferred Stock
link:presentationLink
link:calculationLink
link:definitionLink
995545 - Disclosure - Stock Based Compensation
link:presentationLink
link:calculationLink
link:definitionLink
995555 - Disclosure - Net (Loss) Income per Share ("EPS") Attributable to Common Stockholders
link:presentationLink
link:calculationLink
link:definitionLink
995565 - Disclosure - Commitments and Contingencies
link:presentationLink
link:calculationLink
link:definitionLink
995575 - Disclosure - Income Taxes
link:presentationLink
link:calculationLink
link:definitionLink
995585 - Disclosure - Related Party Transactions
link:presentationLink
link:calculationLink
link:definitionLink
995595 - Disclosure - Employee Benefit Plans
link:presentationLink
link:calculationLink
link:definitionLink
995605 - Disclosure - Segment Information
link:presentationLink
link:calculationLink
link:definitionLink
995615 - Disclosure - Subsequent Events
link:presentationLink
link:calculationLink
link:definitionLink
995625 - Disclosure - Summary of Significant Accounting Policies (Policies)
link:presentationLink
link:calculationLink
link:definitionLink
995635 - Disclosure - Fair Value Measurements and Financial Instruments (Tables)
link:presentationLink
link:calculationLink
link:definitionLink
995645 - Disclosure - Balance Sheet Components (Tables)
link:presentationLink
link:calculationLink
link:definitionLink
995655 - Disclosure - Intangible Assets (Tables)
link:presentationLink
link:calculationLink
link:definitionLink
995665 - Disclosure - Revenue (Tables)
link:presentationLink
link:calculationLink
link:definitionLink
995675 - Disclosure - Leases (Tables)
link:presentationLink
link:calculationLink
link:definitionLink
995685 - Disclosure - Stockholders' Equity (Tables)
link:presentationLink
link:calculationLink
link:definitionLink
995695 - Disclosure - Stock Based Compensation (Tables)
link:presentationLink
link:calculationLink
link:definitionLink
995705 - Disclosure - Net (Loss) Income per Share ("EPS") Attributable to Common Stockholders (Tables)
link:presentationLink
link:calculationLink
link:definitionLink
995715 - Disclosure - Income Taxes (Tables)
link:presentationLink
link:calculationLink
link:definitionLink
995725 - Disclosure - Segment Information (Tables)
link:presentationLink
link:calculationLink
link:definitionLink
995735 - Disclosure - Nature of Operations and Liquidity - Additional Information (Detail)
link:presentationLink
link:calculationLink
link:definitionLink
995745 - Disclosure - Summary of Significant Accounting Policies - Additional Information (Detail)
link:presentationLink
link:calculationLink
link:definitionLink
995755 - Disclosure - Fair Value Measurements and Financial Instruments - Financial Assets and Liabilities Measured at Fair Value (Detail)
link:presentationLink
link:calculationLink
link:definitionLink
995765 - Disclosure - Fair Value Measurements and Financial Instruments - Additional Information (Detail)
link:presentationLink
link:calculationLink
link:definitionLink
995775 - Disclosure - Fair Value Measurements and Financial Instruments - Summary of Assumptions to Fair Value of Warrant Liability Based on Black-Scholes Option Pricing Model (Detail)
link:presentationLink
link:calculationLink
link:definitionLink
995785 - Disclosure - Fair Value Measurements and Financial Instruments - Changes in Estimated Fair Value of Level 3 Financial Assets and Liabilities (Detail)
link:presentationLink
link:calculationLink
link:definitionLink
995795 - Disclosure - Fair Value Measurements and Financial Instruments - Cash Equivalents and Held-to-maturity Debt Securities (Detail)
link:presentationLink
link:calculationLink
link:definitionLink
995805 - Disclosure - Fair Value Measurements and Financial Instruments - Summary of Fair Value and Amortized Cost of Held-to-maturity Debt Securities and Redemption Date (Details)
link:presentationLink
link:calculationLink
link:definitionLink
995815 - Disclosure - Balance Sheet Components - Additional Information (Detail)
link:presentationLink
link:calculationLink
link:definitionLink
995825 - Disclosure - Balance Sheet Components - Schedule of Inventories, Net of Reserves (Detail)
link:presentationLink
link:calculationLink
link:definitionLink
995835 - Disclosure - Balance Sheet Components - Schedule of Accrued Expenses and Other Current Liabilities (Detail)
link:presentationLink
link:calculationLink
link:definitionLink
995845 - Disclosure - Balance Sheet Components - Schedule of Accounts and Note Receivables, Net (Detail)
link:presentationLink
link:calculationLink
link:definitionLink
995855 - Disclosure - Balance Sheet Components - Schedule of Property and Equipment, Net (Detail)
link:presentationLink
link:calculationLink
link:definitionLink
995865 - Disclosure - Intangible Assets - Additional Information (Detail)
link:presentationLink
link:calculationLink
link:definitionLink
995875 - Disclosure - Intangible Assets - Schedule of Carrying Amounts and Accumulated Amortization of Intangible Assets (Detail)
link:presentationLink
link:calculationLink
link:definitionLink
995885 - Disclosure - Intangible Assets - Schedule of Estimated Future Amortization Expense (Detail)
link:presentationLink
link:calculationLink
link:definitionLink
995895 - Disclosure - Revenue - Additional Information (Detail)
link:presentationLink
link:calculationLink
link:definitionLink
995905 - Disclosure - Revenue - Summary of Sales by Product Categories (Detail)
link:presentationLink
link:calculationLink
link:definitionLink
995915 - Disclosure - Leases - Additional Information (Detail)
link:presentationLink
link:calculationLink
link:definitionLink
995925 - Disclosure - Leases - Schedule of Supplemental Cash Flow Information (Detail)
link:presentationLink
link:calculationLink
link:definitionLink
995935 - Disclosure - Leases - Schedule of Present Value Assumptions used in Calculating Present Value of Lease Payments (Detail)
link:presentationLink
link:calculationLink
link:definitionLink
995945 - Disclosure - Leases - Schedule of Maturity of Operating Lease Liabilities (Detail)
link:presentationLink
link:calculationLink
link:definitionLink
995955 - Disclosure - Leases - Schedule of Maturity of Operating Lease Liabilities (Detail) 2
link:presentationLink
link:calculationLink
link:definitionLink
995965 - Disclosure - Stockholders' Equity - Schedule of Common Stock, Reserved for Future Issuance (Detail)
link:presentationLink
link:calculationLink
link:definitionLink
995975 - Disclosure - Stockholders' Equity - Schedule of Common Stock, Reserved for Future Issuance (Parenthetical) (Details)
link:presentationLink
link:calculationLink
link:definitionLink
995985 - Disclosure - Stockholders' Equity - Additional Information (Detail)
link:presentationLink
link:calculationLink
link:definitionLink
995995 - Disclosure - Convertible Preferred Stock - Additional Information (Detail)
link:presentationLink
link:calculationLink
link:definitionLink
996005 - Disclosure - Stock Based Compensation - Additional Information (Detail)
link:presentationLink
link:calculationLink
link:definitionLink
996015 - Disclosure - Stock Based Compensation - Summary of Stock Option Activity (Detail)
link:presentationLink
link:calculationLink
link:definitionLink
996025 - Disclosure - Stock Based Compensation - Fair Values of Award Granted Estimated Using Black-Scholes Valuation Model (Detail)
link:presentationLink
link:calculationLink
link:definitionLink
996035 - Disclosure - Stock Based Compensation - Summary of Stock-Based Compensation Expense Recognized (Detail)
link:presentationLink
link:calculationLink
link:definitionLink
996045 - Disclosure - Net (Loss) Income per Share ("EPS") Attributable to Common Stockholders - Basic and Diluted EPS Attributable to Common Stockholders (Detail)
link:presentationLink
link:calculationLink
link:definitionLink
996055 - Disclosure - Net (Loss) Income per Share ("EPS") Attributable to Common Stockholders - Anti-dilutive Security not Included In Diluted per Share Calculations (Detail)
link:presentationLink
link:calculationLink
link:definitionLink
996065 - Disclosure - Commitments and Contingencies - Additional Information (Detail)
link:presentationLink
link:calculationLink
link:definitionLink
996075 - Disclosure - Income Taxes - Additional Information (Detail)
link:presentationLink
link:calculationLink
link:definitionLink
996085 - Disclosure - Income Taxes - Schedule of Income Tax Provision and Effectie Tax Rate (Detail)
link:presentationLink
link:calculationLink
link:definitionLink
996095 - Disclosure - Related Party Transactions - Additional Information (Detail)
link:presentationLink
link:calculationLink
link:definitionLink
996105 - Disclosure - Employee Benefit Plans - Additional Information (Detail)
link:presentationLink
link:calculationLink
link:definitionLink
996115 - Disclosure - Segment Information - Additional Information (Detail)
link:presentationLink
link:calculationLink
link:definitionLink
996125 - Disclosure - Segment Information - Schedule of Segment Reporting Information (Detail)
link:presentationLink
link:calculationLink
link:definitionLink
996135 - Disclosure - Subsequent Events - Additional Information (Details)
link:presentationLink
link:calculationLink
link:definitionLink
Schedule of Cash Flow, Supplemental Disclosures [Table Text Block]
Schedule of Supplemental Cash Flow Information
Segments [Domain]
Loss from operations
Net (loss) income
Net (loss) income from operations
Net (loss) income
Proceeds from Sale and Maturity of Other Investments
Maturity of certificates of deposit
Concentration Risk Type [Axis]
Entity Incorporation, State or Country Code
Entity Incorporation, State or Country Code
Debt Securities, Held-to-Maturity, Fair Value, Maturity [Abstract]
Fair Value
Preferred Stock, Shares Issued
Preferred stock shares issued
Statement of Financial Position Location, Balance [Domain]
Defined Benefit Plan, Plan Assets, Contributions by Employer
Contributions for employee benefits
Fair Value, Measurement with Unobservable Inputs Reconciliation, Recurring Basis, Liability Value
Balance at December 31, 2025
Balance at March 31, 2026
Increase (Decrease) in Accounts Payable
Accounts payable
Increase (Decrease) in Accounts Payable, Total
Contingent royalty payment description
Contingent Royalty Payment Description
Contingent royalty payment description.
Lease expiration month and year.
Lease Expiration Month And Year
Lease expiration month and year
Plan Name [Axis]
Plan Name
Equity [Abstract]
Entity Current Reporting Status
Entity Current Reporting Status
Operating Expenses [Abstract]
Operating expenses excluding cost of revenues:
Operating expenses:
Fair Value, Inputs, Level 2 [Member]
Fair Value, Inputs, Level 2
Share-Based Compensation Arrangement by Share-Based Payment Award, Options, Outstanding, Weighted Average Exercise Price [Abstract]
Weighted- Average Exercise Price
Common Stock, Shares Authorized
Common stock, shares authorized
Finite-Lived Intangible Asset, Expected Amortization, Year Four
2030
Other Nonoperating Income (Expense) [Member]
Other Expense, Net
Temporary Equity, Par or Stated Value Per Share
Temporary equity, par value
Product and Service [Axis]
Product and Service
Document Fiscal Period Focus
Document Fiscal Period Focus
Nature of operations and liquidity.
Nature Of Operations And Liquidity [Text Block]
Nature of Operations and Liquidity
Revenue from Contract with Customer [Abstract]
Entity Shell Company
Entity Shell Company
Temporary Equity, Shares Outstanding
Temporary Equity, Balance (in shares)
Temporary equity, shares outstanding
Temporary Equity, Balance (in shares)
Contractual amount
Contractual Obligation
Contractual Obligation, Total
Total other accrued liabilities
Other Accrued Liabilities, Current
Other accrued liabilities
Summary Of Significant Accounting Policies [Table]
Summary Of Significant Accounting Policies [Table]
Summary of significant accounting policies.
Inventories
Inventory, Gross
Inventory, Gross, Total
Segments
Segment Reporting, Policy [Policy Text Block]
Cash and Cash Equivalent
Cash and cash equivalents
Cash and Cash Equivalents, at Carrying Value, Total
Litigation Settlement, Fee Expense
Litigation expenses
Receivable Type [Axis]
Receivable Type
Common Stock, Shares, Issued
Common stock, shares issued
Common stock, shares sold
Statement [Table]
Statement [Table]
Contingent royalty payment percentage of sale for twelfth year
Contingent Royalty Payment Percentage of Sale for Twelfth Year
Contingent royalty payment percentage of sale for twelfth year.
Percentage of excess cash on dispositions net.
Percentage Of Excess Cash On Dispositions Net
Percentage of excess cash on dispositions net
Long-Term Purchase Commitment, Category of Item Purchased [Domain]
Income Tax [Table]
Income Tax [Table]
Income Tax [Table]
Contingent Royalty Payment Percentage of Sale for Third Year
Contingent royalty payment percentage of sale for third year.
Contingent royalty payment percentage of sale for third year
Debt Securities, Held-to-Maturity, Amortized Cost, after Allowance for Credit Loss, Maturity, Allocated and Single Maturity Date, after Year One through Five
Due in one to five years
Statement [Line Items]
Statement [Line Items]
Business Combination [Domain]
Business Acquisition, Acquiree
Time Based and Performance Based Awards [Member]
Time-based and performance-based awards.
Time-Based and Performance-Based Awards
Warrant [Member]
Warrant Liability, Noncurrent
Entity Filer Category
Entity Filer Category
Reclassifications
Reclassification, Comparability Adjustment [Policy Text Block]
Derivative Asset, Measurement Input
Derivative asset measurement input
Accrued expenses general and administrative.
Accrued Expenses General and Administrative
Accrued expenses - general and administrative
Cash and cash equivalents reporting currency denominated value.
Cash and Cash Equivalents Reporting Currency Denominated Value
Cash and cash equivalents denominated in RMB
Liabilities and Equity
Total liabilities and stockholders' equity
Debt Securities, Held-to-Maturity, Amortized Cost, after Allowance for Credit Loss, Maturity, Allocated and Single Maturity Date
Total
Credit Concentration Risk [Member]
Credit Concentration Risk
Share-Based Compensation Arrangement by Share-Based Payment Award, Options, Exercisable, Weighted Average Exercise Price
Weighted- Average Exercise Price, Exercisable - March 31, 2026
Long-Lived Tangible Asset [Axis]
N D A Passes the N M P A's Review and Inspection.
N D A Passes the N M P A's Review and Inspection [Member]
NDA Passes the NMPA's Review and Inspection
Incremental Common Shares Attributable to Dilutive Effect of Conversion of Preferred Stock
Weighted average of Convertible Preferred Stock (as converted)
Other Comprehensive Income (Loss), Foreign Currency Transaction and Translation Adjustment, Net of Tax, Portion Attributable to Parent, Total
Other Comprehensive Income (Loss), Foreign Currency Transaction and Translation Adjustment, Net of Tax, Portion Attributable to Parent
Foreign currency translation adjustments
Capital Addition Purchase Commitments [Member]
Property and Equipment
Finite-Lived Intangible Assets, Remaining Amortization Period
Finite-lived intangible assets, Weighted average amortization period
Subsequent Event [Line Items]
Effective Income Tax Rate Reconciliation, Percent, Total
Effective Income Tax Rate Reconciliation, Percent
Effective tax rate
Income Tax Jurisdiction [Axis]
Income Tax Authority
Derivative Liability, Measurement Input
Derivative liability measurement input
Distributions To Holders
Distributions to holders.
Distributions to holders
Contingent royalty payments percentage of sale for eleventh year
Contingent Royalty Payment Percentage of Sale for Tenth Year
Contingent royalty payment percentage of sale for tenth year.
Geographical [Domain]
Payments to Acquire Intangible Assets
Acquisition of intangible assets
Inventory, Finished Goods, Gross
Finished goods
Mainland China Contribution Plan.
Mainland China Contribution Plan [Member]
Mainland China Contribution Plan
Percentage of revenue accounted sales to distributors.
Percentage of revenue accounted sales to distributors
Percentage of revenue accounted sales to distributors
Segment, Expenditure, Addition to Long-Lived Assets
Purchase of property and equipment
Schedule of Inventory, Current [Table Text Block]
Schedule of Inventories, Net of Reserves
Temporary equity, convertible preferred stock conversion, value
Temporary Equity, Convertible Preferred Stock Conversion, Value
Temporary Equity, Convertible preferred stock conversion
Underwriters option period
Underwriters Option Period
Underwriters option period.
Proceeds from sale of other assets
Proceeds from Sale of Other Assets, Investing Activities
Related Party
Related Party [Member]
GNI
Significant Accounting Policies [Text Block]
Summary of Significant Accounting Policies
Property, Plant and Equipment [Line Items]
Land use rights, net assets.
Land Use Rights, Net Assets
Land use rights, net assets
Measurement Input, Risk Free Interest Rate [Member]
Risk-Free Interest
Accounts Payable and Accrued Liabilities, Current [Abstract]
Share-Based Compensation Arrangement by Share-Based Payment Award, Options, Grants in Period, Gross
Number of Shares Underlying Outstanding Options, Options granted
Options granted
Disaggregation of Revenue [Table]
Schedule of Earnings Per Share, Basic and Diluted [Table Text Block]
Basic and Diluted EPS Attributable to Common Stockholders
Investments Classified by Contractual Maturity Date [Table Text Block]
Summary of Fair Value and Amortized Cost of Held-to-maturity Debt Securities and Redemption Date
Earnings Per Share, Basic
Earnings Per Share, Basic, Total
Net (loss) income per share attributable to common stockholders, basic
Net (loss) income per share available for common stockholders, basic
Disaggregation of Revenue [Table Text Block]
Summary of Sales by Product Categories
Deferred Government Grants [Line Items]
Deferred government grants.
Other Comprehensive Income (Loss), Foreign Currency Transaction and Translation Adjustment, Net of Tax, Total
Other Comprehensive Income (Loss), Foreign Currency Transaction and Translation Adjustment, Net of Tax
Foreign currency translation adjustments
Share-Based Compensation Arrangement by Share-Based Payment Award, Options, Outstanding, Number
Number of Shares Underlying Outstanding Options, Ending Balance
Number of Shares Underlying Outstanding Options, Beginning Balance
Options to purchase common stock.
Options To Purchase Common Stock [Member]
Options To Purchase Common Stock
Options Issued and Outstanding
Shanghai Pharmaceuticals Holding Company Limited.
Shanghai Pharmaceuticals Holding Company Limited [Member]
Shanghai Pharmaceuticals Holding Co., Ltd
Liabilities, Current
Total current liabilities
Current liabilities
C V R derivative liability non current member.
C V R Derivative Liability Non Current [Member]
CVR Derivative Liability, Noncurrent
Accounts receivable
Increase (Decrease) in Accounts Receivable
Accounts receivable
Adjustment to Reconcile Net Income to Cash Provided by (Used in) Operating Activity [Abstract]
Adjustments to reconcile net (loss) income to net cash provided by operating activities:
Domestic Tax Jurisdiction [Member]
Federal Income Tax
Other Director Or Executive Officer [Member]
Other director or executive officer.
Other Director or Executive Officer
Accounting Standards Update [Axis]
Accounting Standards Update
Product Concentration Risk [Member]
Sales
ETUARY
Product
2021 ATM Program
Two Thousand Twenty One A T M Program [Member]
Two thousand twenty one ATM program.
Equity, Attributable to Parent [Abstract]
Stockholders' equity:
Fair Value, Assets Measured on Recurring Basis, Unobservable Input Reconciliation [Table Text Block]
Changes in Estimated Fair Value of Level 3 Financial Assets and Liabilities
Entity Small Business
Entity Small Business
Stockholders Equity Disclosure [Line Items]
Stockholders Equity Disclosure [Line Items]
Stockholders equity disclosure.
Retained Earnings (Accumulated Deficit)
Accumulated deficit
Accumulated deficit
Retained Earnings (Accumulated Deficit), Total
Zhengzhou [Member]
Zhengzhou.
Weighted average of preferred stock warrant
Weighted Average Of Preferred Stock Warrant
Weighted average of Preferred Stock Warrants (as converted)
Percentage of amount received on agreement.
Percentage Of Amount Received On Agreement
Percentage of amount received on agreement
Long-term certificates of deposit reporting currency denominated value.
Long-term Certificates of Deposit Reporting Currency Denominated Value
Long-term certificates of deposit denominated in RMB
Preferred Stock [Member]
Preferred Stock
Share-Based Compensation Arrangement by Share-Based Payment Award, Options, Forfeitures in Period
Number of Shares Underlying Outstanding Options, Options forfeited and cancelled
Public offering price
Sale of Stock, Price Per Share
Subsequent Events, Policy [Policy Text Block]
Subsequent Events
Fair value assets and liabilities level1 to level2 transfers amount.
Fair Value Assets and Liabilities Level1 To Level2 Transfers Amount
Fair value measurement transfer between Level 1 and Level 2
Warrants and Rights Outstanding, Measurement Input
Warrants and Rights Outstanding, Measurement Input
Warrants and rights outstanding, measurement input
Share-Based Payment Arrangement [Text Block]
Stock Based Compensation
Organization, Consolidation and Presentation of Financial Statements [Abstract]
Obligation to pay in exchange for the intellectual property rights.
Obligation to pay in exchange for the intellectual property rights
Obligation to pay in exchange for the intellectual property rights
Inventory Valuation Reserves
Inventory reserves
Lessee, Lease, Description [Line Items]
Lessee Lease Description [Line Items]
Amendment Flag
Amendment Flag
Product and Service [Domain]
Product and Service
Percentage of minority interest ownership indirectly holds.
Percentage Of Minority Interest Ownership Indirectly Holds
Minority interest ownership indirectly holds
Noncontrolling Interest
Noncontrolling Interest, Policy [Policy Text Block]
Noncontrolling interest, policy.
Class of Warrant or Right, Number of Securities Called by Warrants or Rights
Warrants to purchase shares
Liabilities and Equity [Abstract]
Liabilities and stockholders' equity
Entity Address, Postal Zip Code
Entity Address, Postal Zip Code
Net cash (used in) provided by operating activities
Cash Provided by (Used in) Operating Activity, Including Discontinued Operation
Net cash provided by operating activities
Net cash provided by operating activities
Payments to Acquire Restricted Certificates of Deposit
Purchase of certificates of deposit
Increase (Decrease) in Operating Lease Liability
Operating lease liabilities
Adjustments to Additional Paid in Capital, Deferred Offering Costs Amortization
Adjustments to additional paid in capital, deferred offering costs amortization.
Deferred Offering Costs Amortization
Common Stock [Member]
Common Stock
General Bank Deposits
General bank deposits.
General bank deposits
CVR liability settlement.
CVR Liability settlement
CVR liability settlement
Share-Based Compensation Arrangements by Share-Based Payment Award, Options, Grants in Period, Weighted Average Exercise Price
Weighted- Average Exercise Price, Options granted
Accumulated Depreciation, Depletion and Amortization, Property, Plant, and Equipment, Total
Accumulated Depreciation, Depletion and Amortization, Property, Plant, and Equipment, Beginning Balance
Accumulated Depreciation, Depletion and Amortization, Property, Plant, and Equipment, Ending Balance
Accumulated Depreciation, Depletion and Amortization, Property, Plant, and Equipment
Less: Accumulated depreciation
Deferred Government Grants [Table]
Deferred government grants.
Debt Securities, Available-for-Sale [Line Items]
Schedule Of Available For Sale Securities [Line Items]
Commitment Payments Based on Spot Exchange Rate
Commitment payments based on spot exchange rate.
Commitment payments based on spot exchange rate
Contingent Value Rights Agreement.
Contingent Value Rights Agreement [Member]
Contingent Value Rights Agreement
Entity Address, Address Line One
Entity Address, Address Line One
Change in Accounting Principle, Accounting Standards Update, Immaterial Effect [true false]
Change in accounting principle, accounting standards update, immaterial effect
Schedule of Share-Based Payment Award, Stock Options, Valuation Assumptions [Table Text Block]
Summary of Weighted-Average Grant Date Fair Value of Options and The Assumptions Used to Estimate Those Fair Value for Time-Based and Performance-Based Awards
China Resources Pharmaceutical Group Limited.
China Resources Pharmaceutical Group Limited [Member]
China Resources Pharmaceutical Group Ltd
Fair Value Hierarchy and NAV [Axis]
Fair Value Hierarchy and NAV
Earnings Per Share [Abstract]
Temporary Equity, Carrying Amount, Attributable to Parent
Temporary Equity, Balance
Temporary Equity, Carrying Amount, Attributable to Parent, Total
Temporary Equity, Balance
Convertible Preferred Stock, $0.001 par value, 5,000,000 shares authorized; nil shares and 13,151 shares issued and outstanding at September 30, 2024 and December 31, 2023, respectively
Supplemental Cash Flow Information [Abstract]
Supplemental Disclosure of Cash Flow Information:
Percentage of vest in substantially equal monthly installments
Percentage Of Vest In Substantially Equal Monthly Installments
Percentage of vest in substantially equal monthly installments.
Statement of Financial Position Location, Balance [Axis]
Investment Type [Axis]
Total
Debt Securities, Held-to-Maturity, Maturity, Allocated and Single Maturity Date, Fair Value
Operating Lease, Right-of-Use Asset
Right-of-use assets
Net Income (Loss) Attributable to Noncontrolling Interest, Total
Less: Allocation of undistributed earnings to noncontrolling interest
Net (loss) income attributable to noncontrolling interest
Less: Allocation of undistributed (losses) earnings to noncontrolling interest
Square meter area for laboratory center under lease.
Square Meter Area For Laboratory Center Under Lease
Square meter area for laboratory center under lease
Square meter area of office space under lease
Temporary equity, convertible preferred stock conversion, shares.
Temporary Equity, Convertible Preferred Stock Conversion, Shares
Temporary Equity, Convertible preferred stock conversion (in shares)
SDM Clinical Trial Agreement
SDM Clinical Trial Agreement [Member]
SDM clinical trial agreement.
Class of Warrant or Right [Axis]
Document Type
Document Type
Net operating loss carryforwards having indefinite life
Operating Loss Carryforwards With Indefinite Life
Operating loss carryforwards with indefinite life.
Income Taxes Paid, Net, Total
Income Taxes Paid, Net
Cash paid for income taxes
Collaborative Arrangement and Arrangement Other than Collaborative [Axis]
Collaborative Arrangement and Arrangement Other than Collaborative
Collaborative Arrangement and Arrangement Other than Collaborative [Domain]
Collaborative Arrangement and Arrangement Other than Collaborative
Entity Central Index Key
Entity Central Index Key
Investments, Debt and Equity Securities [Abstract]
Commitments and contingencies disclosure.
Commitments And Contingencies Disclosure [Line Items]
Commitments And Contingencies Disclosure [Line Items]
Nontrade Receivables, Current
Receivable from GCBP
Cash, Cash Equivalent, Restricted Cash, and Restricted Cash Equivalent, Period Increase (Decrease), Including Exchange Rate Effect and Discontinued Operation
Net increase (decrease) in cash and cash equivalents
Net increase in cash
Subsequent Event Type [Domain]
Subsequent Event Type
Fair Value Adjustment of Warrants
Less: Change in fair value of warrant liability
Change in fair value of warrant liability
Change in fair value of warrant liability
Less: Change in fair value of warrant liability
Antidilutive Securities Excluded from Computation of Earnings Per Share, Amount
Anti dilutive securities
Balance Sheet Related Disclosures [Abstract]
Common Stock, Par or Stated Value Per Share
Common stock, par value
Accounting Standards Update [Domain]
Accounting Standards Update
Issuance of additional shares settled
Sale of Stock, Number of Shares Issued and Settled in Transaction
Sale of stock, number of shares issued and settled in transaction.
Finite lived intangible assets amortization expense after year four.
Finite Lived Intangible Assets Amortization Expense After Year Four
Thereafter
Security Deposit
Security deposits
Fair value, assets and liabilities measured on recurring basis, unobservable input reconciliation.
Fair Value Assets And Liabilities Measured On Recurring Basis Unobservable Input Reconciliation [Line Items]
Fair Value Assets And Liabilities Measured On Recurring Basis Unobservable Input Reconciliation [Line Items]
Proceeds from Issuance of Warrants
Aggregate purchase price of warrants
Share-Based Compensation Arrangement by Share-Based Payment Award, Options, Outstanding, Weighted Average Remaining Contractual Term
Weighted-Average Remaining Contractual Term (Years), Outstanding Balance
Volatility, maximum (%)
Share-Based Compensation Arrangement by Share-Based Payment Award, Fair Value Assumptions, Expected Volatility Rate, Maximum
Aggregate amounts of restricted capital and statutory reserves.
Aggregate Amounts Of Restricted Capital And Statutory Reserves
Aggregate amounts of restricted capital and statutory reserves
Contingent Royalty Payment Percentage of Sale for Eighth Year
Contingent royalty payment percentage of sale for eighth year.
Contingent royalty payment percentage of sale for eighth year
Parent [Member]
Total Gyre Stockholders' (Deficit) Equity
Share-Based Compensation Arrangement by Share-Based Payment Award, Options, Exercises in Period
Issuance of common stock from option exercises, shares
Number of Shares Underlying Outstanding Options, Options exercised
Stock options exercised (in shares)
Accrued Interest Income On Short term Bank Deposits
Accrued interest income on short-term bank deposits.
Accrued interest income on short term bank deposits
Motor vehicles.
Motor Vehicles [Member]
Motor Vehicles
Share-Based Payment Arrangement, Expensed and Capitalized, Amount [Abstract]
Supplemental disclosure of stock-based compensation expense:
Cost of Sales [Member]
Cost of Revenues
Share-Based Payment Arrangement, Expensed and Capitalized, Amount [Line Items]
Share-based Compensation Arrangement by Share-based Payment Award, Compensation Cost [Line Items]
Contingent royalty payment sales for second year
Contingent Royalty Payment Sales for Second Year
Contingent royalty payment sales for second year.
Ownership [Domain]
Current Fiscal Year End Date
Current Fiscal Year End Date
Excess amount retained from net proceeds related to disposition of assets.
Excess Amount Retained From Net Proceeds Related To Disposition Of Assets
Percentage of excess cash on dispositions net
Excess amount retained from net proceeds related to disposition of assets
Document Quarterly Report
Document Quarterly Report
CALIFORNIA
California [Member]
Receivables [Abstract]
Deposits in licensed banks protected by deposit insurance system.
Deposits In Licensed Banks Protected By Deposit Insurance System
Deposits in licensed banks protected by DIS
Fair Value, by Balance Sheet Grouping [Table]
Fair Value By Balance Sheet Grouping [Table]
Entity Address, State or Province
Entity Address, State or Province
Stock Issued During Period, Value, Conversion of Convertible Securities
Convertible preferred stock conversion
Asset Acquisition [Domain]
Asset Acquisition
Comprehensive Income (Loss), Net of Tax, Attributable to Parent
Comprehensive (loss) income attributable to common stockholders
Common Stock, Capital Shares Reserved for Future Issuance
Total common stock reserved
Common stock, shares reserved for future issuance
Incremental Common Shares Attributable to Dilutive Effect of Share-Based Payment Arrangements
Weighted average of common stock options
Class of Warrant or Right [Domain]
Geographical [Axis]
Committed to allocate.
Committed To Allocate
Committed to allocate
Accounts Receivable [Member]
Accounts Receivable
Inventory, Raw Materials, Gross
Raw materials
Equity, Attributable to Noncontrolling Interest, Total
Equity, Attributable to Noncontrolling Interest, Beginning Balance
Equity, Attributable to Noncontrolling Interest, Ending Balance
Equity, Attributable to Noncontrolling Interest
Noncontrolling interest
Share-Based Payment Arrangement, Expensed and Capitalized, Amount [Table Text Block]
Summary of Stock-Based Compensation Expense Recognized
Stock Issued During Period, Value, Stock Options Exercised
Stock options exercised
Contingent Royalty Payment Percentage of Sale for Seventh Year
Contingent royalty payment percentage of sale for seventh year.
Contingent royalty payment percentage of sale for seventh year
Annual Sales Commission For First Two Years Exceeding Amount
Annual sales commission for first two years exceeding amount.
Annual sales commission for first two years exceeding amount
Deferred Income Tax Assets, Net
Deferred tax assets
Subsequent Event [Member]
Subsequent Event
Percentage of Options Vest Immediately On Grant Date
Percentage of options vest immediately on grant date.
Percentage of options vest immediately on grant date
Other Assets, Noncurrent
Other assets, noncurrent
Fair Value Measurement Inputs and Valuation Techniques [Table]
Preferred stock warrants.
Preferred Stock Warrants [Member]
Preferred Stock Warrants Issued and Outstanding
Preferred Stock Warrants
Percentage Of Short Term Bank Deposits Reporting Currency Denominated
Percentage of short term bank deposits reporting currency denominated.
Percentage of short-term bank deposit reporting currency denominated
Antidilutive Securities [Axis]
Antidilutive Securities
GC Biopharma Corp.
G C Biopharma Corp [Member]
GC Biopharma Corp
State Income Tax
State and Local Jurisdiction [Member]
Contiva [Member]
Contiva [Member]
Contiva
AOCI Attributable to Parent [Member]
Accumulated Other Comprehensive Loss
Customer [Domain]
Finite-Lived Intangible Assets, Major Class Name [Domain]
Finite-Lived Intangible Assets, Major Class Name
Cash and Cash Equivalents [Domain]
Cash and Cash Equivalents
May Two Thousand Twenty Five Underwritten Public Offering [Member]
May two thousand twenty five Underwritten Public Offering.
May 2025 Underwritten Public Offering
Other Product [Member]
Other product.
Other Products
Statutory reserve fund.
Statutory Reserve Fund
Statutory reserve fund
Business Combination, Consideration Transferred
Business Combination, Consideration Transferred, Total
Stock transaction
Technology Rights [Member]
Technology rights.
Technology rights
Minimum
Minimum [Member]
Financial Instrument [Axis]
Assets, Current [Abstract]
Current assets:
Etorel
Etorel [Member]
Etorel [Member]
Amortization of Intangible Assets
Amortization of intangible assets
Fair Value, Inputs, Level 3 [Member]
Fair Value, Inputs, Level 3
Noncash lease expense.
Noncash Lease Expense
Noncash lease expense
Segment Reporting [Abstract]
Statutory reserve.
Statutory Reserve
Statutory reserve
Summary Of Significant Accounting Policies [Line Items]
Summary Of Significant Accounting Policies [Line Items]
Summary of significant accounting policies.
Fair Value, Assets Measured on Recurring Basis [Table Text Block]
Financial Assets and Liabilities Measured at Fair Value on a Recurring Basis
Liabilities, Current [Abstract]
Current liabilities:
Product [Member]
ETUARY
Sales of Pharmaceutical Products
Organization And Nature Of Operations [Table]
Organization And Nature Of Operations [Table]
Organization and Nature of Operations [Table]
Number of common stock shares issuable upon exercise and conversion of warrants.
Number of Common Stock Shares Issuable Upon Exercise and Conversion Of Warrants
Number of shares of common stock issuable upon exercise and conversion of warrants
New Accounting Pronouncements Issued But Not Yet Adopted [Policy Text Block]
New Accounting Pronouncements Issued But Not Yet Adopted [Policy Text Block]
New Accounting Pronouncements - Issued But Not Yet Adopted
Related Party Transactions [Abstract]
Bad debt expense and other non-cash items.
Bad Debt Expense And Other Non-cash Items
Bad debt expense and other non-cash items
Shares, Outstanding
Balance (in shares)
Balance (in shares)
Operating Loss Carryforwards
Net operating loss carryforwards
Accounts receivables, net
Accounts Receivable, after Allowance for Credit Loss, Current
Schedule of Accounts, Notes, Loans and Financing Receivable [Table Text Block]
Schedule of Accounts and Note Receivable, Net
Nanjing [Member]
Nanjing.
Commitments and Contingencies
Commitments and Contingencies (Note 11)
Contingent Royalty Payment Sales for First Year
Contingent royalty payment sales for first year.
Contingent royalty payment sales for first year
Inventory, Work in Process, Gross
Work in progress
Contingent Royalty Payment Sales Spot Exchange Rate for First Year
Contingent royalty payment sales spot exchange rate for first year.
Contingent royalty payment sales spot exchange rate for first year
Stock-based compensation expense, shares
Shares Issued, Shares, Share-Based Payment Arrangement, after Forfeiture
Shares Issued, Shares, Share-Based Payment Arrangement, after Forfeiture, Total
General and Administrative Expense [Member]
General and Administrative
General and administrative
Other Comprehensive Income (Loss), Foreign Currency Transaction and Translation Adjustment, Net of Tax, Portion Attributable to Noncontrolling Interest
Foreign currency translation adjustments attributable to noncontrolling interest
Operating Lease, Liability
Operating lease, liability
Total lease liabilities
Accounts Receivable, before Allowance for Credit Loss, Current
Accounts receivable
Forecast [Member]
Forecast
Cash Flow, Operating Activities, Lessee [Abstract]
Expected to be Incurred Beyond One Year [Member]
Expected to be incurred beyond one year.
Expected to be Incurred Beyond One Year
Concentration Risk Benchmark [Axis]
Category of Item Purchased [Axis]
Contingent Royalty Payment Percentage of Sale for Eleventh Year
Contingent royalty payment percentage of sale for eleventh year.
Contingent royalty payments percentage of sale for eleventh year
Lessee, Lease, Description [Table]
Lessee Lease Description [Table]
Effect of Exchange Rate on Cash, Cash Equivalents, Restricted Cash, and Restricted Cash Equivalents, Including Disposal Group and Discontinued Operations, Total
Effect of Exchange Rate on Cash, Cash Equivalent, Restricted Cash, and Restricted Cash Equivalent, Including Discontinued Operation
Effect of exchange rate changes on cash
Share Based Compensation Arrangement by Share Based Payment Award Percentage of Issued and Outstanding Stock Maximum
Share based compensation arrangement by share based payment award percentage of issued and outstanding stock maximum.
Voting power percentage
Net Income (Loss), Including Portion Attributable to Noncontrolling Interest
Net Income (Loss), Including Portion Attributable to Noncontrolling Interest, Total
Net loss
Net (loss) income
Accrued Income Taxes, Current
Income tax payable
Defined Benefit Plan [Text Block]
Employee Benefit Plans
Weighted-average number of shares used in computing net income (loss) per share available to common stockholders, basic
Weighted average common shares outstanding
Weighted average shares used in calculating net income per share attributable to common stockholders, basic
Weighted average shares used in calculating net (loss) income per share attributable to common stockholders, basic
Scenario [Axis]
Scenario
CVR derivative liability.
C V R Derivative Liability [Member]
CVR Derivative Liability
Remaining outstanding balance of agreement.
Remaining Outstanding Balance of Agreement
Remaining outstanding balance
Foreign currency risk.
Foreign Currency Risk [Policy Text Block]
Foreign Currency Risk
Schedule of Effective Income Tax Rate Reconciliation [Table Text Block]
Schedule of Income Tax Provision and Effectie Tax Rate
Schedule of Share-Based Compensation Arrangements by Share-Based Payment Award [Table]
Schedule Of Share Based Compensation Arrangements By Share Based Payment Award [Table]
Segments [Axis]
Long-Lived Tangible Asset [Domain]
Subsequent Events [Text Block]
Subsequent events
Percentage of outstanding shares of common stock.
Percentage Of Outstanding Shares Of Common Stock
Percentage of outstanding shares of common stock
Appropriation of statutory reserve
Appropriation of statutory reserve
Appropriation of statutory reserve
Related Party Transactions Disclosure [Text Block]
Related Party Transactions
APIC, Share-Based Payment Arrangement, Increase for Cost Recognition
Stock-based compensation expense
APIC, Share-Based Payment Arrangement, Increase for Cost Recognition, Total
Warrants share price.
Warrants Share Price
Warrants share price per share
Equity, Attributable to Parent
Balance
Balance
Total Gyre stockholders' equity
Preferred Stock, Par or Stated Value Per Share
Preferred stock, par value
Preferred stock par value
Basis of Accounting, Policy [Policy Text Block]
Basis of Presentation
Accrued interest on certificates of deposit.
Accrued Interest On Certificates Of Deposit
Accrued interest on certificates of deposit
Distribution from asset sale proceeds.
Distribution From Asset Sale Proceeds
Distribution to CVR holders from asset sale proceeds
CPI contribution.
C P I Contribution [Member]
CPI Contribution
Statement of Stockholders' Equity [Abstract]
Equity Method Investments
Total investment
Increase (Decrease) in Notes Receivables
Notes receivable
Accounts and financing receivable, allowance for credit loss, current.
Accounts and Financing Receivable, Allowance for Credit Loss, Current
Allowance for credit losses
2026
Use of Estimates, Policy [Policy Text Block]
Use of Estimates
Payment for Research and Development under Agreement
Payment for research and development under agreement.
Payment for research and development under agreement
Defined Benefit Plan Disclosure [Line Items]
Over-Allotment Option [Member]
Over-Allotment Option
Greenshoe Option
Selling and Marketing Expense [Member]
Selling and Marketing
Entity Address, Address Line Two
Entity Address, Address Line Two
Fair Value Disclosures [Text Block]
Fair Value Measurements and Financial Instruments
UNITED STATES
Noncontrolling Interest [Member]
Non-controlling Interest
Share-Based Compensation Arrangement by Share-Based Payment Award, Options, Outstanding [Roll Forward]
Number of Shares Underlying Outstanding Options
Commissions and offering costs
Commissions And Offering Costs
Commissions and offering costs.
Noncash Investing and Financing Items [Abstract]
Supplemental Disclosure of Non-Cash Financing and Investing Activities:
Measurement Input, Discount Rate [Member]
Estimated Discount Rate
Accrued Liabilities and Other Liabilities
Accrued expenses and other current liabilities
Value Of Cash Balances Exceeded Securities Investor Protection Corporation Insurance Limit
Value of cash balances exceeded securities investor protection corporation insurance limit.
Cash balances exceeded securities investor protection corporation insurance limit
Contingent Royalty Payment Percentage of Sale for Fourth Year
Contingent royalty payment percentage of sale for fourth year.
Contingent royalty payment percentage of sale for fourth year
Plan Name [Domain]
Plan Name
Percentage of commission for shares sold
Percentage Of Commission For Shares Sold
Percentage of Commission for shares sold.
Fair Value, Measurement with Unobservable Inputs Reconciliation, Recurring Basis, Liability, Settlements
Change due to settlements
Fair Value, Assets and Liabilities Measured on Recurring and Nonrecurring Basis [Line Items]
Fair Value, Assets and Liabilities Measured on Recurring and Nonrecurring Basis [Line Items]
Transaction Costs
Transaction costs.
Transaction costs
Building [Member]
Buildings
Total Consideration Of Intangible Assets
Total consideration of intangible assets.
Total Consideration Of Intangible Assets
Cost of Product and Service Sold
Cost of Goods and Services Sold, Total
Cost of revenues
Cost of revenues
Appropriations to statutory reserve.
Appropriations To Statutory Reserve
Appropriations to statutory reserve
Increase (Decrease) in Income Taxes Payable, Net of Income Taxes Receivable
Income tax payable
Lessee, Operating Lease, Liability, to be Paid, Fiscal Year Maturity [Abstract]
Investment Subscription Amount
Investment subscription amount.
Investment obligation amount
Related and Nonrelated Parties [Axis]
Cumulative amount of statutory reserve fund.
Cumulative Amount Of Statutory Reserve Fund
Cumulative amount of statutory reserve fund
Withholding individual income tax on Employee Stock Options
Withholding Individual Income Tax On Employee Stock Options
Withholding individual income tax on employee stock options.
Entity Address, City or Town
Entity Address, City or Town
Cash, FDIC Insured Amount
FDIC insured deposits amount per depositor
Financing Receivable, before Allowance for Credit Loss, Current
Note receivable
Financing Receivable, after Allowance for Credit Loss, Current
Financing Receivable, after Allowance for Credit Loss, Current, Total
Notes receivable
Sublease arrangement.
Sublease Arrangement [Member]
Sublease Arrangement
Number of reportable segment
Number of Reportable Segments
Amortization of land use rights.
Amortization Of Land Use Rights
Amortization of land use rights
Security Exchange Name
Security Exchange Name
Property, Plant and Equipment, Gross, Total
Property, Plant and Equipment, Gross, Beginning Balance
Property, Plant and Equipment, Gross, Ending Balance
Property, Plant and Equipment, Gross
Property and equipment, gross
Continent pharmaceuticals inc.
Continent Pharmaceuticals Inc [Member]
CPI
Intangible Assets Disclosure [Text Block]
Intangible Assets
Counterparty Name [Axis]
Counterparty Name
Income (Loss) from Continuing Operations before Income Taxes, Noncontrolling Interest
(Loss) income before income taxes
Concentration Risk Type [Domain]
Technology-Based Intangible Assets [Member]
Technological know-how
Stockholders Equity Disclosure [Table]
Stockholders Equity Disclosure [Table]
Stockholders equity disclosure.
Measurement Input Type [Domain]
Measurement Input Type
Antidilutive Securities, Name [Domain]
Antidilutive Securities, Name
Inventory, Net
Inventories, net
Inventories
Increase (Decrease) in Due to Related Parties, Total
Increase (Decrease) in Due to Related Parties
Due to related parties
Share-Based Payment Arrangement, Expensed and Capitalized, Amount [Table]
Schedule Of Employee Service Share Based Compensation Allocation Of Recognized Period Costs [Table]
Statistical Measurement [Domain]
Statistical Measurement
Short Term Bank Deposits [Member]
Short-term bank deposits.
Short-term Bank Deposits
Class of Warrant or Right, Exercise Price of Warrants or Rights
Warrants exercise price per share
Assets, Current
Total current assets
Current assets
Share-Based Payment Arrangement, Expense
Total stock-based compensation
Stock-based compensation
Document Period End Date
Document Period End Date
Fair Value Hierarchy and NAV [Domain]
Fair Value Hierarchy and NAV
Options exercisable for shares
Share-Based Compensation Arrangement by Share-Based Payment Award, Options, Exercisable, Number
Number of Shares Underlying Outstanding Options, Exercisable- March 31, 2026
Accrued Expenses and Other Current Liabilities
Accrued Expenses and Other Current Liabilities [Member]
Accrued expenses and other current liabilities.
Gain (Loss) on Disposition of Property Plant Equipment, Total
Gain (Loss) on Disposition of Property Plant Equipment
Loss on disposal of property and equipment
Loss on disposal of property and equipment
Accrued Salaries, Current
Employee reimbursement
Statement of Financial Position [Abstract]
GC Biophrarma Corp asset purchase agreement member.
G C Biophrarma Corp Asset Purchase Agreement [Member]
GCBP Asset Purchase Agreement
Redeemable Convertible Preferred Stock [Member]
Redeemable Convertible Preferred Stock
Contributions closing payable amount.
Contributions Closing Payable Amount
Contributions closing payable amount
Antidilutive Security, Excluded EPS Calculation [Table]
Schedule Of Antidilutive Securities Excluded From Computation Of Earnings Per Share [Table]
Other Comprehensive Income (Loss), Net of Tax, Portion Attributable to Parent [Abstract]
Other comprehensive (loss) income:
Deposits In Licensed Banks Spot Exchange Rate
Deposits in licensed banks spot exchange rate.
Deposits in licensed banks spot exchange rate
Class of Stock [Axis]
Class of Stock
Other Receivables
Other receivables
Percentage of excess preapproved costs.
Percentage Of Excess Preapproved Costs
Percentage of excess preapproved costs
Warrants and Rights Outstanding, Maturity Date
Expiration date
Accrued payroll and welfare.
Accrued Payroll And Welfare
Accrued payroll and welfare
Liabilities
Total liabilities
Financial Instruments [Domain]
Debt Securities, Held-to-Maturity, Amortized Cost, after Allowance for Credit Loss, Maturity, Allocated and Single Maturity Date, Year One
Due in one year
Performance-based awards, description
Share-Based Compensation Arrangement by Share-Based Payment Award, Description
Long-term Certificates of Deposit
Long Term Certificates Of Deposit [Member]
Long-term certificates of deposit.
Due in one year
Debt Securities, Held-to-Maturity, Fair Value, Maturity, Allocated and Single Maturity Date, Year One
Share-Based Compensation Arrangement by Share-Based Payment Award, Award Requisite Service Period
Service Period
Sinopharm Group Company Limited.
Sinopharm Group Company Limited [Member]
Sinopharm Group Co., Ltd
Lessee, Operating Lease, Liability, to be Paid, Year Two
2028
Non-cash acquisition of property and equipment through prepaid conversion
Non-cash Acquisition of Property And Equipment Through Prepaid Conversion
Non-cash acquisition of property and equipment through prepaid conversion
Finite-Lived Intangible Assets, Gross, Total
Finite-Lived Intangible Assets, Gross
Gross carrying amount
Machinery and electronic devices.
Machinery and Electronic Devices [Member]
Machinery and Electronic Devices
Weighted Average Number of Shares Outstanding, Diluted
Weighted-average number of shares used in computing net income (loss) per share available to common stockholders, diluted
Weighted average shares used in calculating net (loss) income per share attributable to common stockholders, diluted
Weighted average shares used in calculating net income per share attributable to common stockholders, diluted
Property, Plant and Equipment, Net, by Type [Abstract]
Securities Act File Number
Entity File Number
Cover [Abstract]
Share-Based Compensation Arrangement by Share-Based Payment Award, Fair Value Assumptions, Expected Volatility Rate, Minimum
Volatility, minimum (%)
F three five one.
F Three Five One [Member]
F351
Measurement Input Type [Axis]
Measurement Input Type
Percentage of short-term bank deposits and long-term certificates of deposit reporting currency denominated.
Percentage of short-term bank deposits and long-term certificates of deposit
Prepaid Expense and Other Assets, Current
Prepaid assets and other current assets
Investments [Domain]
Supplemental Balance Sheet Disclosures [Text Block]
Balance Sheet Components
Series B Convertible Preferred Stock [Member]
Series b convertible preferred stock.
Series B Convertible Preferred Stock
Revenue Benchmark [Member]
Revenue
Scenario [Domain]
Scenario
Number of shares authorized
Share-Based Compensation Arrangement by Share-Based Payment Award, Number of Shares Authorized
Number of Operating Segments
Number of operating segment
Deferred income tax expense benefit net.
Deferred Income Tax Expense Benefit Net
Deferred income taxes, net
Sale of Stock [Domain]
Segment Reporting Disclosure [Text Block]
Segment Information
General and administrative
General and Administrative Expense
General and Administrative Expense, Total
Minimum payments based on spot exchange rate
Minimum Payments Based on Spot Exchange Rate
Minimum payments based on spot exchange rate
Revenue from Contract with Customer, Including Assessed Tax
Revenue from sales
Total Product Revenue
Research and Development Expense Recognized
Research and development expense recognized
Research and development expense recognized
Expected to be Incurred Within One Year
Expected to be Incurred Within One Year [Member]
Expected to be incurred within one year.
Subsequent Event [Table]
Legal expenses incurred
Legal Expenses Incurred
Legal expenses incurred.
Finite-Lived Intangible Assets, Net, Beginning Balance
Finite-Lived Intangible Assets, Net, Ending Balance
Finite-Lived Intangible Assets, Net
Intangible assets, net
Intangible assets, net
Commitments Disclosure [Text Block]
Commitments and Contingencies
Operating Lease, Expense
Operating lease expense
Lease renewed month and year
Lease Renewed Month And Year
Lease renewed month and year.
Accounting Standards Update 202505 [Member]
Accounting Standards Update 2025-05.
ASU 2025-05
Share-Based Compensation Arrangement by Share-Based Payment Award, Options, Additional Disclosures [Abstract]
Weighted-Average Remaining Contractual Term (Years)
New Accounting Pronouncements, Policy [Policy Text Block]
Accounting Pronouncements Recently Adopted
Lessee, Operating Lease, Liability, to be Paid, Maturity [Table Text Block]
Schedule of Maturity of Operating Lease Liabilities
Antidilutive Securities Excluded from Computation of Earnings Per Share [Line Items]
Antidilutive Securities Excluded From Computation Of Earnings Per Share [Line Items]
Contract liabilities
Contract with Customer, Liability, Current
Debt Securities, Held-to-Maturity, Amortized Cost, after Allowance for Credit Loss, Maturity [Abstract]
Amortized Cost
Stock Issued During Period, Shares, Conversion of Convertible Securities
Convertible preferred stock conversion (in shares)
Ownership [Axis]
Cash paid for equity method investment
Payment for equity method investment.
Payment For Equity Method Investment
Cash paid for equity method investment
Risk-free interest rate, minimum (%)
Share-Based Compensation Arrangement by Share-Based Payment Award, Fair Value Assumptions, Risk Free Interest Rate, Minimum
Investment, Type [Extensible Enumeration]
Operating loss carryforwards expiration year.
Operating Loss Carryforwards Expiration Year
Net operating loss carryforwards expiration year
Amounts receivable from related party
Other Receivables, Net, Current
Other Receivables, Net, Current, Total
Other receivables from GNI
Long-Term Investments, Total
Long-Term Investments
Long-term investments
Common Stock, Shares, Outstanding
Common stock, shares outstanding
Common Stock, Shares, Outstanding, Beginning Balance
Common Stock, Shares, Outstanding, Ending Balance
Operating Lease, Liability, Current
Less current portion of lease liabilities
Operating lease liabilities, current
Depreciation, Depletion and Amortization
Depreciation and amortization
Depreciation, Depletion and Amortization, Total
Document Transition Report
Document Transition Report
Short-Term Investments, Total
Short-Term Investments
Short-term bank deposits
Operating Expenses
Total operating expenses
Risks And Uncertainities [Policy Text Block]
Risks And Uncertainities [Policy Text Block]
Risks and Uncertainities
Research and Development Expense
Research and development
Research and Development Expense, Total
Research and development fees
Debt Securities, Held-to-Maturity, Fair Value
Debt Securities, Held-to-Maturity, Fair Value, Total
Estimated Fair Value
Receivable [Domain]
Receivable
Lessee, Operating Leases [Text Block]
Leases
Convertible Preferred Stock [Member]
Convertible Preferred Stock
Convertible Preferred Stock Issued and Outstanding
Gyre Pharmaceuticals
Gyre Pharmaceuticals [Member]
Gyre Pharmaceuticals
Beijing [Member]
Beijing.
Comprehensive Income (Loss), Net of Tax, Including Portion Attributable to Noncontrolling Interest
Comprehensive income from consolidated operations
Comprehensive (loss) income from operations
Statement of Cash Flows [Abstract]
Square Meter Area For Staff Dormitory Under Lease
Square meter area for staff dormitory under lease.
Square meter area for staff dormitory under lease
Stock Issued During Period, Value, New Issues
Issuance of Common Stock in ATM Program
Share-Based Payment Arrangement, Option, Activity [Table Text Block]
Summary of Stock Option Activity
Installment Payments Due Based on Spot Exchange Rate
Installment payments due based on spot exchange rate.
Installment payments due based on spot exchange rate
Schedule of common stock reserved for future issuance.
Schedule Of Common Stock Reserved For Future Issuance [Table Text Block]
Schedule of Common Stock, Reserved for Future Issuance
Equity [Text Block]
Stockholders' Equity
Finite-Lived Intangible Assets [Line Items]
Earnings Per Share [Text Block]
Net (Loss) Income per Share ("EPS") Attributable to Common Stockholders
Fair Value, Measurement with Unobservable Inputs Reconciliation, Recurring Basis, Asset Value
Balance at March 31, 2025
Balance at December 31, 2024
Net income (loss) and comprehensive income (loss)
Net income (loss)
Increase (Decrease) in Inventories, Total
Increase (Decrease) in Inventories
Inventories
Percentage of indirect ownership interest.
Percentage Of Indirect Ownership Interest
Indirect ownership interest
Pharmaceutical Products [Member]
Pharmaceutical products member.
Pharmaceutical Products
CVR derivative liability noncurrent.
C V R Derivative Liability Noncurrent
CVR derivative liability, noncurrent
CVR derivative liability
Warrants and Rights Outstanding, Term
Term (years)
Songjiang Ma [Member]
Songjiang Ma.
Songjiang Ma
F351 asset purchase agreement.
F Three Five One Asset Purchase Agreement [Member]
F351 Agreement
Share-Based Compensation Arrangement by Share-Based Payment Award, Fair Value Assumptions, Expected Dividend Rate
Dividend yield (%)
Operating Lease, Payments
Cash paid for amounts included in the measurement of lease liabilities
Assets [Abstract]
Assets
Research and Development Arrangement [Member]
Research and Development
Share-Based Compensation Arrangement by Share-Based Payment Award, Fair Value Assumptions, Risk Free Interest Rate
Risk-free interest rate (%)
Construction in Progress [Member]
Construction in Progress
Increase (Decrease) in Prepaid Expense and Other Assets
Prepaid assets and other current assets
Change in fair value of long-term receivables.
Change In Fair Value Of Long Term Receivables
Change in fair value of long-term receivables
Document Fiscal Year Focus
Document Fiscal Year Focus
Concentration Risk Benchmark [Domain]
Changes in fair value
Fair Value, Measurement with Unobservable Inputs Reconciliation, Recurring Basis, Liability, Period Increase (Decrease)
Fair Value, Measurement with Unobservable Inputs Reconciliation, Recurring Basis, Liability, Period Increase (Decrease), Total
Cash Provided by (Used in) Investing Activity, Including Discontinued Operation [Abstract]
Investing Activities
Retirement Benefits [Abstract]
Accounts Payable, Current
Accounts payable
Accounts Payable, Current, Total
Deferred government grants.
Deferred Government Grants
Deferred government grants
Commitments and contingencies disclosure.
Commitments And Contingencies Disclosure [Table]
Commitments And Contingencies Disclosure [Table]
Research and Development Expense [Member]
Research and Development
Other Operating Segment [Member]
Other
Proceeds from Sale of Productive Assets, Total
Proceeds from Sale of Productive Assets
Proceeds from sale of equipment
Fair Value, Measurement with Unobservable Inputs Reconciliation, Recurring Basis, Asset, Period Increase (Decrease)
Changes in fair value
Fair Value, Measurement with Unobservable Inputs Reconciliation, Recurring Basis, Asset, Period Increase (Decrease), Total
Statutory Reserve.
Statutory Reserve [Member]
Statutory Reserve
Finite-Lived Intangible Asset, Expected Amortization, Year One
2027
Other Liabilities, Total
Other Liabilities
Due to related parties
Proceeds from Stock Options Exercised
Proceeds from the exercise of stock options
Fair Value Disclosures [Abstract]
Commitments and Contingencies Disclosure [Abstract]
Lessee, Operating Lease, Liability, to be Paid, Year One
2027
Net Income (Loss) Available to Common Stockholders, Basic
Net income from operations
Net income attributable to common stockholders - basic
Net (loss) income available to common stockholders
Share-Based Payment Arrangement [Abstract]
Assets, Fair Value Disclosure
Assets, fair value
Assets, Fair Value Disclosure, Total
Sale of Stock [Axis]
Percentage of equity interest
Percentage Of Equity Interest
Percentage of equity interest.
Concentration of customer risk
Concentration risk percentage
Total Product Revenue, Percentage
Cash Provided by (Used in) Investing Activity, Including Discontinued Operation
Net cash (used in) provided by investing activities
Title of 12(b) Security
Title of 12(b) Security
Schedule of Segment Reporting Information, by Segment [Table]
Share-Based Compensation Arrangements by Share-Based Payment Award, Options, Forfeitures in Period, Weighted Average Exercise Price
Weighted- Average Exercise Price, Options forfeited and cancelled
Money Market Funds
Money Market Funds [Member]
Related and Nonrelated Parties [Domain]
Share based compensation arrangement by share based payment award weighted average share price.
Share Based Compensation Arrangement By Share Based Payment Award Weighted Average Share Price
Weighted average share price of the Company (USD per share)
Income Tax Disclosure [Text Block]
Income Taxes
Temporary Equity, Shares Issued
Temporary equity, shares issued
Committed to allocate in future
Committed To Allocate In Future
Committed to allocate in future.
Weighted Average Number of Shares Issued, Basic
Weighted average common shares outstanding
Lessee, Operating Lease, Liability, to be Paid, Remainder of Fiscal Year
Remaining in 2026
Other Liabilities, Noncurrent
Other noncurrent liabilities
Adjustment to Reconcile Net Income to Cash Provided by (Used in) Operating Activity, Increase (Decrease) in Operating Capital [Abstract]
Changes in operating assets and liabilities:
Property, Plant and Equipment [Table Text Block]
Schedule of Property and Equipment, Net
Share-Based Compensation Arrangement by Share-Based Payment Award, Options, Outstanding, Weighted Average Exercise Price
Weighted- Average Exercise Price, Ending Balance
Weighted- Average Exercise Price, Beginning Balance
Preferred Stock [Text Block]
Convertible Preferred Stock
Due in one to five years
Debt Securities, Held-to-Maturity, Fair Value, Maturity, Allocated and Single Maturity Date, after Year One Through Five
Income Tax Disclosure [Abstract]
Fair Value, Recurring and Nonrecurring [Table]
Fair Value Assets And Liabilities Measured On Recurring And Nonrecurring Basis [Table]
Additional Paid-in Capital [Member]
Additional Paid-In Capital
Increase (Decrease) in Accrued Liabilities and Other Operating Liabilities
Accrued expenses and other liabilities
Exchange ratio
Exchanging Ratio
Exchanging ratio.
Statement of Income Location, Balance [Axis]
Income Statement Location
Change in Accounting Principle, Accounting Standards Update, Adoption Date
Change in accounting principle, accounting standards update, adoption date
Trading Symbol
Trading Symbol
Intangible Asset, Finite-Lived [Table]
Related Party Transaction [Table]
Share-Based Compensation Arrangement by Share-Based Payment Award, Fair Value Assumptions, Risk Free Interest Rate, Maximum
Risk-free interest rate, maximum (%)
Subsequent Event Type [Axis]
Subsequent Event Type
Schedule of Finite-Lived Intangible Assets [Table Text Block]
Schedule of Gross Carrying Amounts and Accumulated Amortization of Intangible Assets
Cash Provided by (Used in) Financing Activity, Including Discontinued Operation [Abstract]
Financing Activities
Share-Based Compensation Arrangement by Share-Based Payment Award, Fair Value Assumptions, Expected Term
Expected option life (in years)
Lessee, Operating Lease, Liability, to be Paid
Total undiscounted lease payments
Accrued expenses, research and development.
Accrued Expenses, Research And Development
Accrued expenses - research and development
Lessee, Operating Lease, Liability, Undiscounted Excess Amount
Less: imputed interest
Fair Value Measurement Inputs and Valuation Techniques [Line Items]
Selling and Marketing Expense, Total
Selling and Marketing Expense
Selling and marketing
Equity Components [Axis]
Equity Components
Accounts and Financing Receivable, after Allowance for Credit Loss, Current
Accounts and note receivables, net
Accounts and note receivables, net
Research and Development Expense (Excluding Acquired in Process Cost)
Research and development
Equity Component [Domain]
Equity Component
Financing Receivable [Member]
Receivable from GCBP
Goodwill and Intangible Assets Disclosure [Abstract]
Deferred Revenue, Noncurrent, Total
Deferred Revenue, Noncurrent
Deferred government grants
Payment of initial investment
Payment Of Initial Investment
Payment of initial investment.
Business Combination [Axis]
Business Acquisition
Redeemable Preferred Stock
Redeemable Preferred Stock [Member]
Customer [Axis]
Measurement Input, Option Volatility [Member]
Expected Volatility
Fair value, assets and liabilities measured on recurring basis, unobservable input reconciliation.
Fair Value Assets And Liabilities Measured On Recurring Basis Unobservable Input Reconciliation [Table]
Fair Value Assets And Liabilities Measured On Recurring Basis Unobservable Input Reconciliation [Table]
Long Term Certificates Of Deposit
Long Term Certificates Of Deposit
Long-term certificates of deposit
Maximum [Member]
Maximum
Liabilities, Fair Value Disclosure
Liabilities, fair value
Liabilities, Fair Value Disclosure, Total
Statistical Measurement [Axis]
Statistical Measurement
Amount of Securities Investor Protection Corporation protects customer assets held Limit
Amount of securities investor protection corporation protects customer assets held limit.
Amount of securities investor protection corporation protects customer assets held limit
Share-Based Compensation Arrangements by Share-Based Payment Award, Options, Exercises in Period, Weighted Average Exercise Price
Weighted- Average Exercise Price, Options Exercised
Finite-Lived Intangible Assets, Accumulated Amortization
Accumulated amortization
Accumulated amortization
N M P A's Approval of the N D A.
N M P A's Approval of the N D A [Member]
NMPA's Approval of the NDA
Common Stock, Value, Issued
Common stock, $0.001 par value, 400,000,000 shares authorized; 91,337,121 shares and 91,314,007 shares issued and outstanding at March 31, 2026 and December 31, 2025, respectively
Shanghai [Member]
Shanghai.
Nintedanib IP Rights [Member]
Nintedanib IP rights.
Nintedanib IP Rights
Net income attributable to common stockholders - diluted
Net Income (Loss) Available to Common Stockholders, Diluted
Net income attributable to common stockholders - diluted
Net (loss) income attributable to common stockholders - diluted
Contingent Royalty Payment Percentage of Sale for Second Year
Contingent royalty payment percentage of sale for second year.
Contingent royalty payment percentage of sale for second year
CVR derivative liability, noncurrent
Long-term CVR derivative liability
Contingent value rights derivative liability non current.
Contingent Value Rights Derivative Liability Non Current
Equity, Including Portion Attributable to Noncontrolling Interest
Total equity
Balance
Balance
Contingent Royalty Payment Percentage of Sale for Sixth Year
Contingent royalty payment percentage of sale for sixth year.
Contingent royalty payment percentage of sale for sixth year
Income Tax [Line Items]
Income Tax.
Income Tax [Line Items]
Vertex Asset Purchase Agreement.
Vertex Asset Purchase Agreement [Member]
Vertex Asset Purchase Agreement
Net Proceeds from Cvr Liability Settlement
Net proceeds from CVR liability settlement.
Net proceeds from CVR liability settlement
Concentration of customer risk.
Concentration of Customer Risk [Policy Text Block]
Concentration of Customer Risk
Distributions to holders per CVR
Distributions To Holders Per CVR
Distributions to holders per CVR.
Submission of the New Drug Application.
Submission of the New Drug Application [Member]
Submission of the New Drug Application
Schedule of Finite-Lived Intangible Assets, Future Amortization Expense [Table Text Block]
Schedule of Estimated Future Amortization Expense
Other Nonoperating Income (Expense) [Abstract]
Other income, net:
Share-Based Compensation Arrangement by Share-Based Payment Award, Fair Value Assumptions, Expected Volatility Rate
Volatility (%)
Comprehensive Income (Loss), Net of Tax, Attributable to Noncontrolling Interest
Comprehensive (loss) income attributable to noncontrolling interest
Costs and Expenses
Total operating expenses
Finite-Lived Intangible Assets by Major Class [Axis]
Finite-Lived Intangible Assets by Major Class
Accrued Sales Rebates Current
Accrued sales rebates current.
Accrued sales rebates
Gross Unrealized Gains
Accumulated Gross Unrealized Gain Before Tax Available For Sale Securities
Accumulated gross unrealized gain before tax available for sale securities.
Payments For Exchange For Intellectual Property Rights
Payments for exchange for intellectual property rights.
Payments for exchange of intellectual property rights
Fair Value, Balance Sheet Grouping, Financial Statement Captions [Line Items]
Fair Value Balance Sheet Grouping Financial Statement Captions [Line Items]
Cash, Cash Equivalent, and Investment [Table Text Block]
Cash Equivalents and Held-to-maturity Debt Securities
Related Party Transaction [Line Items]
Revenue from Contract with Customer [Text Block]
Revenue
Entity Registrant Name
Entity Registrant Name
Short-Term Bank Deposits Reporting Currency Denominated Value
Short-Term Bank Deposits Reporting Currency Denominated Value
Short-term bank deposits denominated in RMB
Customer Concentration Risk [Member]
Customer Concentration Risk
Contingent Royalty Payment Percentage of Sale for First Year
Contingent royalty payment percentage of sale for first year.
Contingent royalty payment percentage of sale for first year
Lessee Disclosure [Abstract]
Finite-Lived Intangible Asset, Expected Amortization, Year Two
2028
Other Nonoperating Income (Expense)
Other Nonoperating Income (Expense), Total
Other income, net
Other (expense) income, net
Additional Paid in Capital
Additional paid-in capital
Additional Paid in Capital, Total
Share-Based Payment Arrangement, Option, Exercise Price Range, Exercisable, Weighted Average Exercise Price
Stock options were granted, exercise price
Subsequent Events [Abstract]
Accounts Payable and Accrued Liabilities, Current
Accrued expenses and other current liabilities
Finite-Lived Intangible Asset, Expected Amortization, Year Three
2029
Income tax expense
Income tax expense (benefits)
Income Tax Expense (Benefit), Total
Provision for income taxes
Income tax provision
Income tax expense
Gyre.
Gyre [Member]
Gyre
Proceeds from Issuance of Common Stock
Aggregate purchase price paid by investors
Proceeds from the issuance of common stock in ATM Program
Fair Value, Measurement with Unobservable Inputs Reconciliation, Recurring Basis, Asset, Settlements
Change due to settlements
Share-Based Compensation Arrangement by Share-Based Payment Award [Line Items]
Share-based Compensation Arrangement by Share-based Payment Award [Line Items]
Fair Value Measurement Inputs and Valuation Techniques [Table Text Block]
Summary of Assumptions to Fair Value of Warrant Liability Based on Black-Scholes Option Pricing Model
Entity Common Stock, Shares Outstanding
Entity Common Stock, Shares Outstanding
Concentration Risk, Credit Risk, Policy [Policy Text Block]
Concentration of Credit Risk
Accumulated Other Comprehensive Income (Loss), Net of Tax, Total
Accumulated Other Comprehensive Income (Loss), Net of Tax
Accumulated other comprehensive income (loss)
Percentage of long-term certificates of deposits reporting currency denominated
Percentage Of Long Term Certificates Of Deposits Reporting Currency Denominated
Percentage of long term certificates of deposits reporting currency denominated.
Organization and Nature of Operations [Line Items]
Organization And Nature Of Operations [Line Items]
Organization and nature of operations.
Payments to Acquire Property, Plant, and Equipment, Total
Payments to Acquire Property, Plant, and Equipment
Purchase of property and equipment
Purchase of property and equipment
Contingent Royalty Payment Sales Spot Exchange Rate for Second Year
Contingent royalty payment sales spot exchange rate for second year.
Contingent royalty payment sales spot exchange rate for second year
Cash balances exceeded federal deposit insurance corporation insurance limit
Value Of Cash Balances Exceeded Federal Deposit Insurance Corporation Insurance Limit
Value of cash balances exceeded federal deposit insurance corporation insurance limit.
Assets
Total assets
Total assets
Finite-Lived Intangible Assets, Net [Abstract]
Intangible assets with finite lives:
Property, Plant and Equipment [Table]
Share-Based Compensation Arrangement by Share-Based Payment Award, Options, Exercisable, Weighted Average Remaining Contractual Term
Weighted Average Remaining Contractual Term, Exercisable - March 31, 2026
Income Statement [Abstract]
Retirement Plan Name [Domain]
Contractual term
Share-Based Payment Arrangement, Option, Exercise Price Range, Exercisable, Weighted Average Remaining Contractual Term
2023 Incentive Plan
Two Thousand Twenty Three Omnibus Incentive Plan [member]
Two thousand twenty three omnibus incentive plan.
2023 Omnibus Incentive Plan
Common stock issue and sold
Sale of Stock, Number of Shares Issued in Transaction
Stock Issued During Period, Shares, New Issues
Issuance of Common Stock in ATM Program (in shares)
Temporary Equity, Shares Authorized
Temporary equity, shares authorized
Share Based Compensation Arrangement by Share Based Payment Award, Options, Exercised, Weighted Average Remaining Contractual Term
Share-based compensation arrangement by share-based payment award, options, exercised, weighted average remaining contractual term.
Weighted Average Remaining Contractual Term, Options exercised
Earnings Per Share, Diluted
Earnings Per Share, Diluted, Total
Net (loss) income per share attributable to common stockholders, diluted
Net (loss) income per share available for common stockholders, diluted
Schedule of Segment Reporting Information, by Segment [Table Text Block]
Schedule of Segment Reporting Information
Change in fair value of derivative liabilities.
Change In Fair Value Of Derivative Liabilities
Change in fair value of derivative liabilities
Asset Acquisition [Axis]
Asset Acquisition
City Area Code
City Area Code
Number of shares of common stock issuable upon conversion of the outstanding shares.
Number Of Shares Of Common Stock Issuable Upon Conversion Of The Outstanding Shares
Hydronidone [Member]
Hydronidone [Member]
Hydronidone
Revenue from Contract with Customer, Product and Service Benchmark [Member]
ETUARY
Sales
Total consideration of intangible assets
Consideration of Intangible Assets
Consideration of Intangible Assets
Defined Benefit Plan [Table]
Counterparty Name [Domain]
Counterparty Name
Operating Lease, Weighted Average Remaining Lease Term
Weighted-average remaining lease term
Segment Reporting Information [Line Items]
Computer Software, Intangible Asset [Member]
Computer software
Retirement Plan Name [Axis]
Fair value assets and liabilities level3 transfers amount.
Fair Value Assets and Liabilities Level3 Transfers Amount
Fair value measurement transfer Level 3
Cullgen [Member]
Cullgen member.
Cullgen
Payable to selling expense suppliers
Payable To Selling Expense Suppliers
Payable to selling expense suppliers.
Property, Plant and Equipment, Net
Property and equipment, net
Property and equipment, net
Cash, Cash Equivalent, Restricted Cash, and Restricted Cash Equivalent, Including Discontinued Operation
Cash, Cash Equivalents, Restricted Cash, and Restricted Cash Equivalents, Including Disposal Group and Discontinued Operations, Total
Cash at beginning of the period
Cash at end of period
Operating Income (Loss)
Income (loss) from operations
(Loss) income from operations
Retained Earnings [Member]
Accumulated Deficit
Accrued interest income on long term certificates of deposit
Accrued Interest Income On Long Term Certificates Of Deposit
Accrued interest income on long-term certificates of deposit.
Entity Address, Country
Entity Address, Country
Purchase agreement amendment date.
Purchase Agreement Amendment Date
Purchase agreement amendment date
Combined square meter area for manufacturing facilities under lease.
Combined Square Meter Area For Manufacturing Facilities Under Lease
Combined square meter area for manufacturing facilities under lease
Cash and Cash Equivalents [Axis]
Cash and Cash Equivalents
Staff Dormitory Lease Expiration Month And Year
Staff dormitory lease expiration month and year.
Staff dormitory lease expiration month and year
Share-Based Payment Arrangement, Noncash Expense
Stock-based compensation expense
Share-Based Payment Arrangement, Noncash Expense, Total
Stock-based compensation
Percentage of cash and cash equivalents reporting currency denominated.
Percentage of cash and cash equivalents
Issuance cost wrote off
Payments of Stock Issuance Costs
Number of installements for sale
Number of installements for sale
Number of installements for sale
Contingent Royalty Payment Percentage of Sale for Ninth Year
Contingent royalty payment percentage of sale for ninth year.
Contingent royalty payments percentage of sale for ninth year
Operating Lease, Weighted Average Discount Rate, Percent
Weighted-average discount rate
Annual Sales Commission Spot Exchange Rate For First Two Years Exceeding Amount
Annual sales commission spot exchange rate for first two years exceeding amount.
Annual sales commission spot exchange rate for first two years exceeding amount
Operating Lease, Liability, Noncurrent
Lease liabilities, net of current portion
Operating lease liabilities, noncurrent
Fair Value, Inputs, Level 1 [Member]
Fair Value, Inputs, Level 1
Equity gain loss of unconsolidated affiliates.
Equity Gain Loss of Unconsolidated Affiliates
Equity in loss of unconsolidated affiliate
Class of Stock [Line Items]
Cash Provided by (Used in) Financing Activity, Including Discontinued Operation
Net cash provided by financing activities
Change in Accounting Principle, Accounting Standards Update, Adopted [true false]
Change in accounting principle, accounting standards update, adopted
Jiangsu wangao agreement.
Jiangsu Wangao Agreement [Member]
Jiangsu Wangao Agreement
Convertible preferred stock conversion.
Convertible Preferred Stock Conversion
Convertible preferred stock conversion
Derivative Liability, Noncurrent
Warrant liability, noncurrent
GNI
G N I [Member]
GNI
GNI Group
Contingent Royalty Payment Percentage of Sale for Fifth Year
Contingent royalty payment percentage of sale for fifth year.
Contingent royalty payment percentage of sale for fifth year
Other long-term investment
Other Long-Term Investments [Member]
Schedule of Antidilutive Securities Excluded from Computation of Earnings Per Share [Table Text Block]
Anti-dilutive Security not Included in Diluted per Share Calculations
CVR derivative liability
C V R Derivative Liability Current
C V R derivative liability current.
Income Tax Jurisdiction [Domain]
Income Tax Authority
Debt Securities, Available-for-Sale [Table]
Schedule Of Available For Sale Securities [Line Items]
Entity Interactive Data Current
Entity Interactive Data Current
Statement of Income Location, Balance [Domain]
Income Statement Location
Cash Provided by (Used in) Operating Activity, Including Discontinued Operation [Abstract]
Operating Activities
Furniture and Fixtures [Member]
Furniture and Fixtures
Preferred stock, shares issued upon conversion
Convertible Preferred Stock, Shares Issued upon Conversion
Two Thousand Twenty Four A T M Program [Member]
Two thousand twenty four atm program.
2024 ATM Program
Summary of present value assumptions of lease payments.
Summary Of Present Value Assumptions Of Lease Payments Table [Text Block]
Schedule of Present Value Assumptions used in Calculating Present Value of Lease Payments
Debt Securities, Held-to-Maturity, Amortized Cost, after Allowance for Credit Loss
Debt Securities, Held-to-Maturity, Amortized Cost, after Allowance for Credit Loss, Total
Amortized Cost
Increase (Decrease) in Other Noncurrent Liabilities
Other noncurrent liabilities
Investment Related Cash
Investment related cash.
Investment related cash
Entity Tax Identification Number
Entity Tax Identification Number
Accrued interest on long-term certificates of deposit.
Accrued Interest On Long-term Certificates Of Deposit
Accrued interest on long-term certificates of deposit
Payable To PPE And Intangible Asset Suppliers
Payable to PPE and intangible asset suppliers.
Payable to property and equipment & intangible asset suppliers
Contingent Royalty Minimum Payment
Contingent royalty minimum payment.
Contingent royalty minimum payment
Proceeds from Issuance or Sale of Equity, Total
Proceeds from Issuance or Sale of Equity
Proceeeds from issuance of aggregate gross sales
Local Phone Number
Local Phone Number
Accrued contract consideration
Accrued Contract Consideration
Accrued contract consideration.
Other Liabilities, Current
Due to related parties
Share-Based Payment Arrangement, Nonvested Award, Option, Cost Not yet Recognized, Amount
Unrecognized employee stock based compensation expense
Short-Term Lease, Cost
Short-term lease expenses
Payments of Financing Costs
Payments of Financing Costs, Total
Deferred financing costs
Accounting Policies [Abstract]
Disaggregation of Revenue [Line Items]
Revenue from Contract with Customer, Excluding Assessed Tax
Revenues
Revenues
Inventory, Net [Abstract]
Cash and Cash Equivalents [Member]
Cash and Cash Equivalents
Class of Stock [Domain]
Class of Stock
Square meter area for office space under lease.
Square Meter Area For Office Space Under Lease
Square meter area for office space under lease
Share-Based Payment Arrangement, Nonvested Award, Cost Not yet Recognized, Period for Recognition
Unrecognized employee stock based compensation expense, period for recognition
Professional and consulting services
Accrued Professional Fees, Current
Accrued professional services
Cash and cash equivalents, short-term bank deposits and long-term certificates of deposits exceeding China DIS coverage
Value Of Assets Exceeding Deposit Insurance System Limit
Value of assets exceeding deposit insurance system limit.
Affiliates
Affiliated Entity [Member]
Schedule of Accounts Payable and Accrued Liabilities [Table Text Block]
Schedule of Accrued Expenses and Other Current Liabilities
Amount to be received under agreement.
Amount To Be Received Under Agreement
Amount to be received under agreement
Stock, Class of Stock [Table]
Etorel IP Rights [Member]
Etorel IP Rights [Member]
Etorel IP Rights
Entity Emerging Growth Company
Entity Emerging Growth Company